Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-06

Clinical Trial Update: Reduction of Zygomatic Arch in Zygomaticomaxillary Fractures [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for reduction of zygomatic arch in zygomaticomaxillary fractures reports Phase 1 and Phase 2 studies, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Alexandria University | Conditions: Zygomatic Arch Reduction | Phase 1, Phase 2 | Status: COMPLETED